Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 11 Feb 2025 for Marinus Pharmaceuticals, INC., €2,854. Read the official filing
Filing timeline
BuySaleMarvin Johnson
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Marvin Johnson: trading record in brief
All filings by Marvin Johnson on record concern Marinus Pharmaceuticals, Inc. The record holds 5 filings, for trades running from 17 April 2023 to 7 February 2025.
No open-market purchase appears, only 1 sale worth €834. The rest of the record consists of 3 share grants. 2025 to date brings no purchases and 1 sale.
On 11 February 2025 came the latest disclosure, a transaction for €2,854 in Marinus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marvin Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
5,389 shares@ US$0.5577.4% of flowCommon StockSEC:0001104659-25-011244:0
1,610 shares@ US$0.5422.6% of flowCommon StockSEC:0001415889-25-001928:0
2,300 shares0Common StockSEC:0001415889-24-017637:0
4,600 shares0Common StockSEC:0001415889-24-001603:0
7,200 shares0Common StockSEC:0001415889-23-006687:0
5 of 5 declarations
